Sponsor pipeline

Capital Development Authority (CDA) clinical trial pipeline

1 active trials 0 recruiting 1 disease areas 4 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

NCT ID	Title	Condition	Status	Updated
Not applicable
NCT07708337	Evaluating Customized Antibiotic Duration (CDA) Strategy in Acute Exacerbations of COPD	COPD	Not Yet Recruiting	2026-10-07

Get alerts when Capital Development Authority (CDA)'s trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.